Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 7(1): e30431, 2012.
Article in English | MEDLINE | ID: mdl-22276197

ABSTRACT

Oligopeptidase B, a processing enzyme of the prolyl oligopeptidase family, is considered as an important virulence factor in trypanosomiasis. Trypanosoma cruzi oligopeptidase B (OPBTc) is involved in host cell invasion by generating a Ca(2+)-agonist necessary for recruitment and fusion of host lysosomes at the site of parasite attachment. The underlying mechanism remains unknown and further structural and functional characterization of OPBTc may help clarify its physiological function and lead to the development of new therapeutic molecules to treat Chagas disease. In the present work, size exclusion chromatography and analytical ultracentrifugation experiments demonstrate that OPBTc is a dimer in solution, an association salt and pH-resistant and independent of intermolecular disulfide bonds. The enzyme retains its dimeric structure and is fully active up to 42°C. OPBTc is inactivated and its tertiary, but not secondary, structure is disrupted at higher temperatures, as monitored by circular dichroism and fluorescence spectroscopy. It has a highly stable secondary structure over a broad range of pH, undergoes subtle tertiary structure changes at low pH and is less stable under moderate ionic strength conditions. These results bring new insights into the structural properties of OPBTc, contributing to future studies on the rational design of OPBTc inhibitors as a promising strategy for Chagas disease chemotherapy.


Subject(s)
Protozoan Proteins/chemistry , Protozoan Proteins/metabolism , Serine Endopeptidases/chemistry , Serine Endopeptidases/metabolism , Trypanosoma cruzi/metabolism , Virulence Factors/chemistry , Virulence Factors/metabolism , Chromatography, Gel , Circular Dichroism , Protein Multimerization , Spectrometry, Fluorescence , Temperature
2.
BMC Biochem ; 12: 46, 2011 Aug 23.
Article in English | MEDLINE | ID: mdl-21861921

ABSTRACT

BACKGROUND: Pathogens depend on peptidase activities to accomplish many physiological processes, including interaction with their hosts, highlighting parasitic peptidases as potential drug targets. In this study, a major leucyl aminopeptidolytic activity was identified in Trypanosoma cruzi, the aetiological agent of Chagas disease. RESULTS: The enzyme was isolated from epimastigote forms of the parasite by a two-step chromatographic procedure and associated with a single 330-kDa homohexameric protein as determined by sedimentation velocity and light scattering experiments. Peptide mass fingerprinting identified the enzyme as the predicted T. cruzi aminopeptidase EAN97960. Molecular and enzymatic analysis indicated that this leucyl aminopeptidase of T. cruzi (LAPTc) belongs to the peptidase family M17 or leucyl aminopeptidase family. LAPTc has a strong dependence on neutral pH, is mesophilic and retains its oligomeric form up to 80°C. Conversely, its recombinant form is thermophilic and requires alkaline pH. CONCLUSIONS: LAPTc is a 330-kDa homohexameric metalloaminopeptidase expressed by all T. cruzi forms and mediates the major parasite leucyl aminopeptidolytic activity. Since biosynthetic pathways for essential amino acids, including leucine, are lacking in T. cruzi, LAPTc could have a function in nutritional supply.


Subject(s)
Leucyl Aminopeptidase/chemistry , Leucyl Aminopeptidase/metabolism , Protein Multimerization , Trypanosoma cruzi/enzymology , Amino Acid Sequence , Cytoplasm/metabolism , Drug Discovery , Hydrolysis , Leucyl Aminopeptidase/classification , Leucyl Aminopeptidase/isolation & purification , Molecular Sequence Data , Phylogeny , Protein Structure, Quaternary , Protein Transport , Sequence Alignment , Trypanosoma cruzi/cytology , Trypanosoma cruzi/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...